observed increased expression of genes related to NF-κB and Notch signaling pathways in patients with large total BTS based on immune-related gene expression profiling analysis of tumor tissue from patients with NSCLC before PD-1/PD-L1 inhibitors treatment (24). This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.